A Bayesian Implementation of Quality-by-Design for the Development of Cationic Nano-Lipid for siRNA Transfection.

Unlike Quality by Testing approach, where products were tested only after drug manufacturing, Quality by Design (QbD) is a proactive control quality paradigm, which handles risks from the early development steps. In QbD, regression models built from experimental data are used to predict a risk mapping called Design Space in which the developers can identify values of critical input factors leading to acceptable probabilities to meet the efficacy and safety specifications for the expected product. These empirical models are often limited to quantitative responses.

Macrophage autophagy protects mice from cerium oxide nanoparticle-induced lung fibrosis.

Background: Cerium (Ce) is a rare earth element, rapidly oxidizing to form CeO, and currently used in numerous commercial applications, especially as nanoparticles (NP). The potential health effects of Ce remain uncertain, but literature indicates the development of rare earth pneumoconiosis accompanied with granuloma formation, interstitial fibrosis and inflammation. The exact underlying mechanisms are not yet completely understood, and we propose that autophagy could be an interesting target to study, particularly in macrophages.

Enrichment of nanoparticles and bacteria using electroless and manual actuation modes of a bypass nanofluidic device.

Current efforts in nanofluidics aimed at detecting scarce molecules or particles are focused mainly on the development of electrokinetic-based devices. However, these techniques require either integrated or external electrodes, and a potential drop applied across a carrier fluid. One challenge is to develop a new generation of electroless passive devices involving a simple technological process and packaging without embedded electrodes for micro- and nanoparticles enrichment with a view to applications in biology such as the detection of viral agents or cancers biomarkers.